PMID: 17310045Feb 21, 2007Paper

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

Annals of Internal Medicine
Shawn D AaronCanadian Thoracic Society/Canadian Respiratory Clinical Research Consortium

Abstract

Treatment of moderate or severe chronic obstructive pulmonary disease (COPD) with combinations of inhaled corticosteroids, long-acting beta-agonists, and long-acting anticholinergic bronchodilators is common but unstudied. To determine whether combining tiotropium with salmeterol or fluticasone-salmeterol improves clinical outcomes in adults with moderate to severe COPD compared with tiotropium alone. Randomized, double-blind, placebo-controlled trial conducted from October 2003 to January 2006. 27 academic and community medical centers in Canada. 449 patients with moderate or severe COPD. 1 year of treatment with tiotropium plus placebo, tiotropium plus salmeterol, or tiotropium plus fluticasone-salmeterol. The primary end point was the proportion of patients who experienced an exacerbation of COPD that required treatment with systemic steroids or antibiotics. The proportion of patients in the tiotropium plus placebo group who experienced an exacerbation (62.8%) did not differ from that in the tiotropium plus salmeterol group (64.8%; difference, -2.0 percentage points [95% CI, -12.8 to 8.8 percentage points]) or in the tiotropium plus fluticasone-salmeterol group (60.0%; difference, 2.8 percentage points [CI, -8.2 to 13.8 perc...Continue Reading

Citations

Nov 14, 2008·Journal of General Internal Medicine·Gerald W Smetana, Jane S Sillman
Oct 26, 2010·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Servet BölükbasJoachim Schirren
Aug 26, 2011·The New England Journal of Medicine·Richard K AlbertUNKNOWN COPD Clinical Research Network
Oct 6, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Makoto Hoshino, Junichi Ohtawa
Mar 3, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jean Bourbeau
Jul 25, 2009·International Journal of Clinical Practice·T Welte
Apr 28, 2007·BMJ : British Medical Journal·Peter D Burrill
Apr 4, 2009·Clinical Trials : Journal of the Society for Clinical Trials·James A BlumenthalCharles F Emery
Feb 23, 2013·The European Respiratory Journal·Pascal L M L WieldersJohn H Riley
May 9, 2013·Respiratory Research·Donald P Tashkin, Gary T Ferguson
Jan 26, 2011·BMC Pulmonary Medicine·Pilar Barnestein-FonsecaFrancisca Leiva-Fernández
Jan 1, 2010·Multidisciplinary Respiratory Medicine·Claudio F Donner, Mirco Lusuardi
Sep 11, 2012·Multidisciplinary Respiratory Medicine·Natasha Duborija-Kovacevic, Milica Martinovic
May 6, 2008·Proceedings of the American Thoracic Society·Malcolm M DeCampByron M Thomashow
May 6, 2008·Proceedings of the American Thoracic Society·Jeremy A FalkZab Mosenifar
May 6, 2008·Proceedings of the American Thoracic Society·Philip T DiazByron M Thomashow
Jan 1, 2010·ClinicoEconomics and Outcomes Research : CEOR·Shalini NaikThomas J Mattei
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Pedro Plans-Rubió
Feb 12, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Ken M Kunisaki, Thomas S Rector
Aug 17, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Christopher B CooperSteven Kesten
Aug 8, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Andrea Rossi, Guido Polese
Mar 22, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Abebaw M YohannesNicola A Hanania
Dec 12, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Kesavaperumal Vijayasaratha, Robert A Stockley
Dec 12, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Felicia C Allen-RameyMarco DaCosta DiBonaventura
May 14, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Carl LlorUNKNOWN BRAMOX Study Group
Jul 16, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Ekaterina S GladyshevaRobert L Owens
Nov 6, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Arnulf LanghammerUnni Syversen
Oct 15, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Tomoko BetsuyakuPaul W Jones
Aug 18, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Paul A FordPeter J Barnes
Apr 7, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Donald P Tashkin
Nov 29, 2013·Drug Design, Development and Therapy·Annette J TheronRonald Anderson
Aug 7, 2010·Drug Design, Development and Therapy·Mark A Giembycz, Stephen K Field
Jan 5, 2011·Journal of Multidisciplinary Healthcare·David A SonettiSandra G Adams
Nov 7, 2012·The Canadian Journal of Hospital Pharmacy·Roxanne DaultMarie-France Beauchesne
Mar 7, 2013·The Canadian Journal of Hospital Pharmacy·John R Manderville
Jun 26, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Terence A R SeemungalJadwiga A Wedzicha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
Peter M A CalverleyTORCH investigators
Respiration; International Review of Thoracic Diseases
Kai RichterHelgo Magnussen
Journal of Managed Care Pharmacy : JMCP
Daniel E Hilleman
International Journal of Chronic Obstructive Pulmonary Disease
Tomotaka KawayamaKurume COPD Study Group
© 2021 Meta ULC. All rights reserved